This page shows the latest Alios BioPharna news and features for those working in and with pharma, biotech and healthcare.
Johnson &Johnson has acquired California-based clinical stage biopharma company Alios BioPharma for $1.75bn. ... The acquisition will include Alios BioPharma's preclinical programmes that target influenza and rhinovirus, as well as RSV.
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
We help communications teams to thrive under pressure. Here at fox&cat, we help all kinds of teams to fight all...